1. At a Glance – The Chemical Veteran That Forgot How to Grow
Excel Industries is that 80-year-old uncle at a wedding who keeps telling stories of how he once dominated the market… while everyone else is busy building unicorn startups.
This company is literally a pioneer — started in 1941, first phosphorus plant in India, global leader in DETC, top 5 in phosphonates. Sounds like a chemical superhero, right?
But then you look at the numbers…
Revenue? Stagnant.
ROE? 5%.
Stock performance? Flat for 5 years.
Margins? Playing musical chairs.
And suddenly this “industry veteran” starts looking less like a tiger and more like a retired lion who occasionally roars but mostly naps.
But wait… before you dismiss it — there’s drama.
✔ Demand recovery
✔ New contract manufacturing deal
✔ ₹200–300 Cr capex plan
✔ China+1 tailwind
✔ Specialty chemicals push
And then…
❌ GST notices
❌ Product concentration risk
❌ Falling margins YoY
❌ Capital allocation confusion
So the real question is:
Is Excel Industries a turnaround story… or just a legacy company slowly fading into irrelevance?
Let’s investigate like a slightly sarcastic chemical detective.
2. Introduction – The Rise, Fall & Confusion of a Chemical OG
Excel Industries is not some new-age startup trying to “disrupt chemicals with AI.”
No.
This company has been around since your grandfather was figuring out how to use a radio.
Originally focused on agrochemical intermediates, it gradually expanded into:
- Specialty chemicals
- Polymer additives
- Pharma intermediates
- Waste management
Sounds diversified, right?
But here’s the twist:
Despite decades of experience and technological expertise… growth has been inconsistent.
From the data:
- FY25 revenue: ₹978 Cr
- TTM revenue: ₹1,061 Cr
- 5-year sales growth: just ~6.8%
- Profit growth (5 yrs): NEGATIVE
That’s not “steady compounding”… that’s “existence”.
Then FY24 happened — chemical sector slowdown due to China dumping supply.
Margins crashed to ~3%.
FY25 saw recovery:
- EBITDA margin jumped to ~12.2%
- Revenue grew 18% YoY
Now FY26?
Growth is there… but margins are again slipping.
So you have:
👉 Cyclical business
👉 Product concentration
👉 Weak capital efficiency
And management saying: “Trust the process.”
Question for you:
How many times will you trust the process before asking for results?
3. Business Model – WTF Do They Even Do?
Let’s simplify.
Excel Industries is basically a chemical middleman with a PhD.
It makes complex chemicals that go into:
- Agrochemicals (pesticides, herbicides)
- Water treatment
- Soaps & detergents
- Pharma APIs
- Polymer additives
Its biggest product?
👉 DETC (Diethylthiophosphoryl Chloride)
Contribution:
Which means…
If DETC sneezes… Excel gets pneumonia.
This chemical is used in:
Basically pesticides.
So the business is heavily linked to:
- Agriculture cycles
- Global chemical pricing
- China supply
Now they’ve tried diversification:
✔ Specialty chemicals
✔ Pharma APIs
✔ Biocides
✔ Contract manufacturing
But reality check:
Agrochemical intermediates still dominate.
Even CRISIL politely said:
“High product concentration risk”
Translation:
“Bro… diversify faster.”
Also interesting:
They are
